Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $28,076.44 in Stock

Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) insider Timothy Rolph sold 509 shares of Akero Therapeutics stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $55.16, for a total transaction of $28,076.44. Following the completion of the transaction, the insider now directly owns 189,420 shares […]

Related Keywords

Blackrock , New Zealand General , New Zealand , Wellington , Timothy Rolph , Akero Therapeutics Company Profile , Alkeon Capital Management , Canaccord Genuity Group , Blackrock Inc , Securities Exchange Commission , Nasdaq , Akero Therapeutics Inc , Pricet Rowe Associates Inc , Wellington Management Group , Akero Therapeutics , Get Rating , Exchange Commission , Therapeutics Stock Down , Genuity Group , Lifesci Capital , Partners Management , Capital Management , Management Group , Akero Therapeutics Daily ,